Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Role of PET imaging in adaptive radiotherapy for lymphoma.

Urwin R, Barrington SF, Mikhaeel NG.

Q J Nucl Med Mol Imaging. 2018 Dec;62(4):411-419. doi: 10.23736/S1824-4785.18.03089-3. Review.

PMID:
30497233
2.

Traumatic subungual neuroma.

Whitehouse HJ, Urwin R, Stables G.

Clin Exp Dermatol. 2018 Jan;43(1):65-66. doi: 10.1111/ced.13247. Epub 2017 Oct 21. No abstract available.

PMID:
29055068
3.

Music in the dermatology theatre: what do patients want to listen to?

Whitehouse H, Urwin R, Stables GI.

Br J Nurs. 2017 Jun 8;26(11):588. doi: 10.12968/bjon.2017.26.11.588. No abstract available.

PMID:
28594625
4.

Contact allergy to thioctic acid present in Hypromellose® eye drops.

Craig S, Urwin R, Wilkinson M.

Contact Dermatitis. 2017 Jun;76(6):361-362. doi: 10.1111/cod.12716. No abstract available.

PMID:
28497636
5.

Patch test clinic experience of potential cross-reactivity of isothiazolinones.

Craig S, Urwin R, Latheef F, Wilkinson M.

Contact Dermatitis. 2017 May;76(5):299-300. doi: 10.1111/cod.12741. No abstract available.

PMID:
28386981
6.

Methylisothiazolinone: the epidemic is declining - but not gone.

Urwin R, Craig S, Latheef F, Wilkinson M.

Contact Dermatitis. 2017 May;76(5):301-302. doi: 10.1111/cod.12750. No abstract available.

PMID:
28386974
7.

Methylchloroisothiazolinone and methylisothiazolinone contact allergy: an occupational perspective.

Urwin R, Warburton K, Carder M, Turner S, Agius R, Wilkinson SM.

Contact Dermatitis. 2015 Jun;72(6):381-6. doi: 10.1111/cod.12379. Epub 2015 Mar 25.

PMID:
25810132
8.

UK rates of occupational skin disease attributed to rubber accelerators, 1996-2012.

Warburton KL, Urwin R, Carder M, Turner S, Agius R, Wilkinson SM.

Contact Dermatitis. 2015 May;72(5):305-11. doi: 10.1111/cod.12356. Epub 2015 Feb 25.

PMID:
25711250
9.

Tailgating and pregaming by college students with alcohol offenses: patterns of alcohol use and beliefs.

Hustad JT, Mastroleo NR, Urwin R, Zeman S, LaSalle L, Borsari B.

Subst Use Misuse. 2014 Dec;49(14):1928-33. doi: 10.3109/10826084.2014.949008. Epub 2014 Sep 3.

10.

Reducing the strain of dermatological surgery.

Urwin R, Hussain W.

Br J Dermatol. 2015 Feb;172(2):546-7. doi: 10.1111/bjd.13212. Epub 2014 Dec 17. No abstract available.

PMID:
25040782
11.

The comparative effectiveness of individual and group brief motivational interventions for mandated college students.

Hustad JT, Mastroleo NR, Kong L, Urwin R, Zeman S, Lasalle L, Borsari B.

Psychol Addict Behav. 2014 Mar;28(1):74-84. doi: 10.1037/a0034899.

12.

The 'inverted' advancement and inferior rotation of the nasal sidewall (AIRNS) flap for defects of the medial canthus.

Urwin R, Montgomery R, Hussain W.

Br J Dermatol. 2014 Mar;170(3):751-3. doi: 10.1111/bjd.12693. No abstract available.

PMID:
24641693
13.

Polymorphisms in the oxytocin receptor gene are associated with the development of psychopathy.

Dadds MR, Moul C, Cauchi A, Dobson-Stone C, Hawes DJ, Brennan J, Urwin R, Ebstein RE.

Dev Psychopathol. 2014 Feb;26(1):21-31. doi: 10.1017/S0954579413000485. Epub 2013 Sep 23.

PMID:
24059750
14.

Methylchloroisothiazolinone and methylisothiazolinone contact allergy: a new 'epidemic'.

Urwin R, Wilkinson M.

Contact Dermatitis. 2013 Apr;68(4):253-5. doi: 10.1111/cod.12064. No abstract available.

PMID:
23510349
15.

Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation.

Ibarz-Pavón AB, Maclennan J, Andrews NJ, Gray SJ, Urwin R, Clarke SC, Walker AM, Evans MR, Kroll JS, Neal KR, Ala'aldeen D, Crook DW, Cann K, Harrison S, Cunningham R, Baxter D, Kaczmarski E, McCarthy ND, Jolley KA, Cameron JC, Stuart JM, Maiden MC.

J Infect Dis. 2011 Oct 1;204(7):1046-53. doi: 10.1093/infdis/jir466.

16.

The genetic structure of Neisseria meningitidis populations in Cuba before and after the introduction of a serogroup BC vaccine.

Climent Y, Urwin R, Yero D, Martinez I, Martín A, Sotolongo F, Maiden MC, Pajón R.

Infect Genet Evol. 2010 May;10(4):546-54. doi: 10.1016/j.meegid.2010.02.002. Epub 2010 Feb 13.

PMID:
20156598
17.

Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba.

Climent Y, Yero D, Martinez I, Martín A, Jolley KA, Sotolongo F, Maiden MC, Urwin R, Pajón R.

J Clin Microbiol. 2010 Mar;48(3):802-10. doi: 10.1128/JCM.01653-09. Epub 2009 Dec 30.

18.

Genealogical typing of Neisseria meningitidis.

Didelot X, Urwin R, Maiden MC, Falush D.

Microbiology. 2009 Oct;155(Pt 10):3176-86. doi: 10.1099/mic.0.031534-0. Epub 2009 Jul 30.

19.

Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines.

Russell JE, Urwin R, Gray SJ, Fox AJ, Feavers IM, Maiden MC.

Microbiology. 2008 Apr;154(Pt 4):1170-7. doi: 10.1099/mic.0.2007/014761-0.

20.

Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.

Maiden MC, Ibarz-Pavón AB, Urwin R, Gray SJ, Andrews NJ, Clarke SC, Walker AM, Evans MR, Kroll JS, Neal KR, Ala'aldeen DA, Crook DW, Cann K, Harrison S, Cunningham R, Baxter D, Kaczmarski E, Maclennan J, Cameron JC, Stuart JM.

J Infect Dis. 2008 Mar 1;197(5):737-43. doi: 10.1086/527401.

PMID:
18271745
21.

First insights into the evolution of Streptococcus uberis: a multilocus sequence typing scheme that enables investigation of its population biology.

Coffey TJ, Pullinger GD, Urwin R, Jolley KA, Wilson SM, Maiden MC, Leigh JA.

Appl Environ Microbiol. 2006 Feb;72(2):1420-8.

22.

Clonal spread of serogroup W135 meningococcal disease in Turkey.

Kilic A, Urwin R, Li H, Saracli MA, Stratton CW, Tang YW.

J Clin Microbiol. 2006 Jan;44(1):222-4.

23.

Neisserial pilin genes display extensive interspecies diversity.

Aho EL, Urwin R, Batcheller AE, Holmgren AM, Havig K, Kulakoski AM, Vomhof EE, Longfors NS, Erickson CB, Anderson ZK, Dawlaty JM, Mueller JJ.

FEMS Microbiol Lett. 2005 Aug 15;249(2):327-34.

24.

Genetic analysis of meningococci carried by children and young adults.

Claus H, Maiden MC, Wilson DJ, McCarthy ND, Jolley KA, Urwin R, Hessler F, Frosch M, Vogel U.

J Infect Dis. 2005 Apr 15;191(8):1263-71. Epub 2005 Mar 15.

PMID:
15776372
25.
26.

Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.

Urwin R, Russell JE, Thompson EA, Holmes EC, Feavers IM, Maiden MC.

Infect Immun. 2004 Oct;72(10):5955-62.

27.

Multi-locus sequence typing: a tool for global epidemiology.

Urwin R, Maiden MC.

Trends Microbiol. 2003 Oct;11(10):479-87. Review.

PMID:
14557031
28.

Gene-gene interaction between the monoamine oxidase A gene and solute carrier family 6 (neurotransmitter transporter, noradrenalin) member 2 gene in anorexia nervosa (restrictive subtype).

Urwin RE, Bennetts BH, Wilcken B, Lampropoulos B, Beumont PJ, Russell JD, Tanner SL, Nunn KP.

Eur J Hum Genet. 2003 Dec;11(12):945-50.

29.

Investigation of epistasis between the serotonin transporter and norepinephrine transporter genes in anorexia nervosa.

Urwin RE, Bennetts BH, Wilcken B, Beumont PJ, Russell JD, Nunn KP.

Neuropsychopharmacology. 2003 Jul;28(7):1351-5. Epub 2003 May 14.

30.

Genetic basis for nongroupable Neisseria meningitidis.

Dolan-Livengood JM, Miller YK, Martin LE, Urwin R, Stephens DS.

J Infect Dis. 2003 May 15;187(10):1616-28. Epub 2003 Apr 30.

PMID:
12721942
31.

Phylogenetic evidence for frequent positive selection and recombination in the meningococcal surface antigen PorB.

Urwin R, Holmes EC, Fox AJ, Derrick JP, Maiden MC.

Mol Biol Evol. 2002 Oct;19(10):1686-94.

PMID:
12270895
32.

Anorexia nervosa (restrictive subtype) is associated with a polymorphism in the novel norepinephrine transporter gene promoter polymorphic region.

Urwin RE, Bennetts B, Wilcken B, Lampropoulos B, Beumont P, Clarke S, Russell J, Tanner S, Nunn KP.

Mol Psychiatry. 2002;7(6):652-7.

33.

Phenotypic and genotypic approaches to characterization of isolates of Neisseria meningitidis from patients and their close family contacts.

Tzanakaki G, Urwin R, Musilek M, Kriz P, Kremastinou J, Pangalis A, Blackwell CC, Maiden MC.

J Clin Microbiol. 2001 Apr;39(4):1235-40.

34.

Multilocus sequence typing system for Campylobacter jejuni.

Dingle KE, Colles FM, Wareing DR, Ure R, Fox AJ, Bolton FE, Bootsma HJ, Willems RJ, Urwin R, Maiden MC.

J Clin Microbiol. 2001 Jan;39(1):14-23.

35.

Computational methods for meningococcal population studies.

Jolley KA, Urwin R.

Methods Mol Med. 2001;67:357-73. doi: 10.1385/1-59259-149-3:357.

PMID:
21337156
36.

Nucleotide Sequencing of Antigen Genes of Neisseria meningitidis.

Urwin R.

Methods Mol Med. 2001;67:157-72. doi: 10.1385/1-59259-149-3:157.

PMID:
21337144
37.

Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy?

MacLennan JM, Urwin R, Obaro S, Griffiths D, Greenwood B, Maiden MC.

Lancet. 2000 Sep 23;356(9235):1078.

PMID:
11009146
38.

Multilocus sequence typing and antigen gene sequencing in the investigation of a meningococcal disease outbreak.

Feavers IM, Gray SJ, Urwin R, Russell JE, Bygraves JA, Kaczmarski EB, Maiden MC.

J Clin Microbiol. 1999 Dec;37(12):3883-7.

39.

Population genetic and evolutionary approaches to analysis of Neisseria meningitidis isolates belonging to the ET-5 complex.

Bygraves JA, Urwin R, Fox AJ, Gray SJ, Russell JE, Feavers IM, Maiden MC.

J Bacteriol. 1999 Sep;181(18):5551-6.

40.
41.

Structural and evolutionary inference from molecular variation in Neisseria porins.

Derrick JP, Urwin R, Suker J, Feavers IM, Maiden MC.

Infect Immun. 1999 May;67(5):2406-13.

42.

Heterogeneity of the PorB protein in serotype 22 Neisseria meningitidis.

Urwin R, Fox AJ, Musilek M, Kriz P, Maiden MC.

J Clin Microbiol. 1998 Dec;36(12):3680-2.

43.

Molecular variation of meningococcal serotype 4 antigen genes.

Urwin R, Feavers IM, Jones DM, Maiden MC, Fox AJ.

Epidemiol Infect. 1998 Aug;121(1):95-101.

44.

Amplification of the meningococcal porB gene for non-culture serotype characterization.

Urwin R, Kaczmarski EB, Guiver M, Fox AJ, Maiden MC.

Epidemiol Infect. 1998 Jun;120(3):257-62.

45.

Endovascular treatment of pseudoaneurysms with electrolytically detachable coils.

Lempert TE, Halbach VV, Higashida RT, Dowd CF, Urwin RW, Balousek PA, Hieshima GB.

AJNR Am J Neuroradiol. 1998 May;19(5):907-11.

46.

Preliminary experience with an electrolytically detachable fibered coil.

Halbach VV, Dowd CF, Higashida RT, Balousek PA, Urwin RW.

AJNR Am J Neuroradiol. 1998 Apr;19(4):773-7.

47.

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.

Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, Zhang Q, Zhou J, Zurth K, Caugant DA, Feavers IM, Achtman M, Spratt BG.

Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3140-5.

48.

Cavernous internal carotid artery aneurysms treated with electrolytically detachable coils.

Halbach VV, Higashida RT, Dowd CF, Urwin RW, Balousek PA, Lempert TE, Hieshima GB.

J Neuroophthalmol. 1997 Dec;17(4):231-9.

PMID:
9427173
49.

Intravascular stent and endovascular coil placement for a ruptured fusiform aneurysm of the basilar artery. Case report and review of the literature.

Higashida RT, Smith W, Gress D, Urwin R, Dowd CF, Balousek PA, Halbach VV.

J Neurosurg. 1997 Dec;87(6):944-9. Review.

PMID:
9384409
50.

Endovascular therapy for the carotid artery.

Urwin RW, Higashida RT, Halbach VV, Dowd CF, Balousek PA, Hieshima GB.

Neuroimaging Clin N Am. 1996 Nov;6(4):957-73. Review.

PMID:
8824143

Supplemental Content

Support Center